Biden administration announces new actions to help hospitals keep up with omicron

The Biden administration announced new actions on Tuesday designed to help protect individuals against omicron and ensure hospitals and health systems have the resources necessary to combat the variant.

Omicron has now surpassed delta as the dominant coronavirus variant in the U.S., with approximately 73% of new national cases caused by the variant as of Dec. 18, according to the CDC. The new moves are meant to build on the president’s Winter Plan released earlier this month.

As part of the increased support for hospitals, an extra 1,000 military doctors, nurses, paramedics and other medical personnel will be ready to be deployed to institutions during January and February. Six additional emergency response teams comprised of more than 100 clinical experts will also prepare for deployment where needed.

Additionally, Federal Emergency Management Agency teams are working to assess hospitals' needs ahead of possible winter surges, expanding bed capacity and making additional supplies available.

The administration is also making a big testing push, purchasing 500 million at-home, rapid tests that will be sent out for free beginning Jan. 1. The feds will also set up new testing sites across the U.S. before Christmas, with the first opening in New York City this week. 

Gerald E. Harmon, MD, president of the American Medical Association (AMA), which has continually encouraged people to get vaccinated, was quick to back the president’s actions.

“The Biden administration’s announcement today to deploy additional medical personnel to COVID-burdened hospitals and stand up new mass vaccination sites across the country will help alleviate some of the burden on the nation’s already overwhelmed healthcare workforce,” Harmon said Dec. 21.

American Hospital Association (AHA) President and CEO Rick Pollack echoed that sentiment and urged the administration to use “all available tools at their disposal and not leave any resources or support on the sidelines.”

Read more about the announcement here.

""

Matt joined Chicago’s TriMed team in 2018 covering all areas of health imaging after two years reporting on the hospital field. He holds a bachelor’s in English from UIC, and enjoys a good cup of coffee and an interesting documentary.

Around the web

Cardiovascular devices are more likely to be in a Class I recall than any other device type. The FDA's approval process appears to be at least partially responsible, though the agency is working to make some serious changes. We spoke to a researcher who has been tracking these data for years to learn more. 

Updated compensation data includes good news for multiple subspecialties. The new report also examines private equity's impact on employment models and how much male cardiologists earn compared to females.

When drugs are on the FDA’s shortage list, outsourcing facilities can produce their own compounded versions. When the FDA removed tirzepatide from that list with no warning, it created a considerable amount of chaos both behind the scenes and in pharmacies all over the country. 

Trimed Popup
Trimed Popup